000 | 01929 a2200565 4500 | ||
---|---|---|---|
005 | 20250516062103.0 | ||
264 | 0 | _c20120316 | |
008 | 201203s 0 0 eng d | ||
022 | _a1476-5586 | ||
024 | 7 |
_a10.1593/neo.11138 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJazaeri, Amir A | |
245 | 0 | 0 |
_aMolecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _cOct 2011 |
||
300 |
_a899-911 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Transformation, Neoplastic |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCystadenocarcinoma, Serous _xgenetics |
650 | 0 | 4 |
_aEpithelial Cells _xmetabolism |
650 | 0 | 4 |
_aFallopian Tubes _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoblotting |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRetinoblastoma Protein _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aTelomerase _xgenetics |
650 | 0 | 4 | _aTransplantation, Heterologous |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aBryant, Jennifer L | |
700 | 1 | _aPark, Hong | |
700 | 1 | _aLi, Hui | |
700 | 1 | _aDahiya, Neetu | |
700 | 1 | _aStoler, Mark H | |
700 | 1 | _aFerriss, James Stuart | |
700 | 1 | _aDutta, Anindya | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 13 _gno. 10 _gp. 899-911 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.11138 _zAvailable from publisher's website |
999 |
_c21259878 _d21259878 |